Trials / Completed
CompletedNCT02229786
Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms
Buscopan® Plus, Buscopan®, Paracetamol and Placebo: Double-blind Randomized Group Comparison to Investigate the Efficacy and Tolerability of the Film-coated Tablets in Patients With Painful Gastric or Intestinal Spasms
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1,637 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Study to evaluate efficacy and tolerability of Buscopan® plus versus Buscopan®, paracetamol, and placebo in patients with painful gastric or intestinal spasms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buscopan® plus | |
| DRUG | Buscopan® | |
| DRUG | Paracetamol | |
| DRUG | Placebo |
Timeline
- Start date
- 1998-02-01
- Primary completion
- 1999-10-01
- First posted
- 2014-09-01
- Last updated
- 2014-09-01
Source: ClinicalTrials.gov record NCT02229786. Inclusion in this directory is not an endorsement.